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Materials and Methods: Using the CBCT of the XRAD225Cx 
preclinical irradiator, 8 tissue equivalent cylinders of known 
composition and density (Gammex RMI, Middelton, WI) were 
imaged at 40kVp. The HU variation was plotted versus the 
product ρ times Zeff that yielded to a monotonically 
increasing curve. Based on this relationship and the tissues 
defined in the ICRU-44 report, interpolated tissues were 
created for ρZeff varying from 2 up to 27 with a 0.2 step. 
Tissue equivalent cylinders were irradiated with the 
XRAD225Cx (225kVp). Exit dose was measured with EBT3 films 
and compared to Monte Carlo (MC) calculations from our 
GATE model of the irradiator. On the CT images, tissue 
segmentation was performed either by manual assignation of 
the elemental composition provided by the manufacturer or 
by using the (HU, ρ, EC) method. Dosimetric impact of the 
(HU, ρ, EC) method was evaluated on mice CT comparing 
with manual segmentation for brain and femoral head 
irradiations. 
Results: Tissue equivalent exit dose measurements relative 
to solid water varied from 1.13 (AP6 adipose) down to 0.36 
(SB3 cortical bone). Max 2% deviation was found with MC dose 
calculation performed with manufacturer data and 4.3% with 
calculation performed with the (HU, ρ, EC) method. Mean 
deviations were respectively 1.1% and 1.8%. It must be 
noticed that the segmentation method was based on real 
human tissues defined in ICRU-44 whereas measurements 
were performed with substitutes with elemental composition 
slightly different from human tissue elemental composition. 
The (HU, ρ, EC) method applied on mice CT allowed the 
automatic definition of 125 tissues. Dosimetric impact of the 
(HU, ρ, EC) was significant for bony tissues (>25%). 
Conclusions: A robust tissue segmentation method was 
developed for dose calculation in preclinical radiation 
therapy based on the (HU, ρZeff) relationship. Our method 
was successfully tested by comparing exit dose 
measurements from materials of known composition with MC 
dose calculation. The method was applied on mice CT for 
brain and femoral head irradiation with significant dosimetric 
impact. 
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Purpose/Objective: To estimate the dosimetric impact of an 
endorectal balloon (ERB) on rectal wall (Rwall) dose 
distribution when using extreme dose constraints during the 
optimization of urethra-sparing prostatic SBRT plans. 
Materials and Methods: A total of ten cT1/3a N0 M0 prostate 
cancer patients, prospectively randomized in an European 
multicenter phase II trial of urethra-sparing SBRT, were 
simulated with and without a 100cc inflated ERB. Patients 
were treated with the ERB following a SBRT protocol of 36.25 
Gy in 5 fractions of 7.25 Gy to the PTV. The dose prescribed 
to the prostatic urethra (urethral planning risk volume, uPRV) 
was reduced to 32.5 Gy. The dose was delivered with two full 
rotational volumetric modulated arcs. Ten plans with ERB 
and ten without (Vmatref) were first optimized until dose 
prescription and normal-tissue constraints (ranging from 50% 
to 100% of prescribed dose) specified in the protocol were 
reached. Additional optimizations based on these 20 Vmatref 
plans were calculated by adding dose constraints to the 
posterior Rwall (D3%, D10% and D20%). Starting from Vmatref 
(with and without ERB), these dose constraints were lowered 
five times to obtain plans Vmat1 to Vmat5. A total of 120 
plans were analyzed. The homogeneity index (HI) for the PTV 
and uPRV were calculated to determine which optimization 
better spared Rwall without degrading the coverage of target 
volumes. Dose-volume histograms were analyzed for Rwall. 
The mean number of monitor units (MU) per optimization 
degree was recorded. 
Results: HI for PTV remained quasi-constant with and without 
ERB from Vmatref until Vmat3 (HI=0.091±0.013 with ERB vs. 
0.079±0.012 without) and then slightly degraded. HI for uPRV 
started at 0.083±0.026 for Vmatref with ERB vs. 0.094±0.025 
without, and constantly deteriorated with higher 
optimizations. For the dose range [8-16 Gy], Vmat3 spared 20 
to 27% more Rwall volume than Vmatref. The mean number of 
MU increased from Vmatref (2028±726) to Vmat4 (2582±877) 
and then dropped off for Vmat5 due to unreachable dose 
constraints.  
ERB vs. no ERB: All plans were similar in the high dose 
regions [24-36 Gy] with a dose ratio ERB/noERB of [1.00–
1.04]. In intermediate dose regions [12-24 Gy], dose ratio 
were below 1 for Vmatref [0.94-0.97], close to 1 for Vmat1,2 
and range [1.04-1.07] for Vmat3. In low dose regions [2.5-12 
Gy] all plans without ERB spared better the Rwall. In very low 
dose regions [0–2.5 Gy], plans with ERB were advantageous 
(dose ratio=0.80).  
Conclusions: Extreme optimization on Rwall is feasible for 
urethra-sparing SBRT without compromising PTV dose 
homogeneity. Dose constraints to the posterior Rwall are now 
added during the optimization process though without 
knowing the potential benefit on rectal toxicity reduction. 
The ERBs do not seem to decrease the high dose received by 
the Rwall but may help to the intrafraction reproducibility of 
volume and shape while on treatment.  
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